Search results for "Target organ damage."

showing 10 items of 18 documents

Value of Home Blood Pressures as Predictor of Target Organ Damage in Mild Arterial Hypertension

2002

Home blood pressure measurement has gained increasing importance for the management of hypertensive patients. The aim of our study was to compare levels of clinic (CBP), ambulatory (ABP), and home blood pressure (HBP) measurements, and their relationships with various indexes of target organ damage in I-II grade essential hypertension.Thirty-eight essential hypertensives underwent evaluation of clinic, ambulatory and home blood pressures. Each patient recorded HBP for 2 days with a digital BP monitor three times daily, the first time on the same day during which ABP monitoring was simultaneously performed. Moreover, in all subjects electrocardiogram recording, echocardiographic study, micro…

AdultMalemedicine.medical_specialtyAmbulatory blood pressureEpidemiologyMultiple Organ FailureStatistics as TopicDiastoleAmbulatory Care FacilitiesSeverity of Illness IndexPrehypertensionPredictive Value of TestsInternal medicineAlbuminuriaHumansMedicinebusiness.industryBlood Pressure Monitoring AmbulatoryMiddle Agedmedicine.diseaseTarget organ damageSurgeryBlood pressureItalyHypertensionAmbulatoryCardiologyFemaleHypertrophy Left VentricularMicroalbuminuriaCardiology and Cardiovascular MedicinebusinessEuropean Journal of Cardiovascular Prevention & Rehabilitation
researchProduct

Influence of metabolic syndrome on hypertension-related target organ damage

2005

MuleG, Nardi E, Cottone S, Cusimano P, Volpe V, Piazza G, MongioviR, Mezzatesta G, Andronico G, Cerasola G (Universitadi Palermo, Palermo, Italy). Influence of metabolic syndrome on hypertension-related target organ damage. J Intern Med 2005; 257: 503-513. Objectives. The aim of our study was to analyse, in a wide group of essential hypertensive patients without diabetes mellitus, the influence of metabolic syndrome (MS) (defined according to the criteria laid down in the Third Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults) on markers of preclinical cardiac, renal and retinal damage. Design. Cros…

AdultMalemedicine.medical_specialtySettore MED/09 - Medicina InternamicroalbuminuriaHeart VentriclesRetinographyLeft ventricular hypertrophyEssential hypertensionKidneyRetinametabolic syndromeHypertensive retinopathyRetinal Diseasesessential hypertension;left ventricular hypertrophy;metabolic syndrome;microalbuminuria;target organ damageInternal medicinetarget organ damageInternal MedicinemedicineAlbuminuriaHumansObesitySex DistributionNational Cholesterol Education ProgramAntihypertensive AgentsBody surface areaSettore MED/14 - Nefrologiabusiness.industryMyocardiumessential hypertensionMiddle Agedmedicine.diseaseSettore MED/11 - Malattie Dell'Apparato Cardiovascolareleft ventricular hypertrophyEndocrinologyCross-Sectional StudiesHypertensionCardiologyRegression AnalysisMicroalbuminuriaFemaleHypertrophy Left VentricularMetabolic syndromebusiness
researchProduct

Metabolic syndrome in hypertensive patients: An unholy alliance

2014

For many years, it has been recognized that hypertension tends to cluster with various anthropometric and metabolic abnormalities including abdominal obesity, elevated triglycerides, reduced high-density lipoprotein cholesterol, glucose intolerance, insulin resistance and hyperuricemia. This constellation of various conditions has been transformed from a pathophysiological concept to a clinical entity, which has been defined metabolic syndrome (MetS). The consequences of the MetS have been difficult to assess without commonly accepted criteria to diagnose it. For this reason, on 2009 the International Diabetes Federation, the American Heart Association and other scientific organizations pro…

Arterial hypertensionmedicine.medical_specialtySettore MED/09 - Medicina InternaEnd organ damageType 2 diabetesOverweightLeft ventricular hypertrophyInsulin resistanceHypertensive retinopathyInternal medicineMedicineTopic HighlightAbdominal obesityTarget organ damageSettore MED/14 - Nefrologiabusiness.industryCardiovascular riskmedicine.diseaseMetabolic syndromeSettore MED/11 - Malattie Dell'Apparato CardiovascolareEndocrinologyCardiologyMetabolic syndromemedicine.symptomCardiology and Cardiovascular Medicinebusiness
researchProduct

The Relationship Between Aortic Root Size and Hypertension: An Unsolved Conundrum

2017

Thoracic aortic aneurysms rupture and dissection are among the most devastating vascular diseases, being characterized by elevated mortality, despite improvements in diagnostic imaging and surgical techniques. An increased aortic root diameter (ARD) represents the main risk factor for thoracic aortic dissection and rupture and for aortic valve regurgitation. Even though arterial hypertension is commonly regarded as a predisposing condition for the development of thoracic aorta aneurysms, the role of blood pressure (BP) as determinant of aortic root enlargement is still controversial. The use of different methods for indexation of ARD may have in part contributed to the heterogeneous finding…

Arterial hypertensionmedicine.medical_specialtySettore MED/09 - Medicina InternaPrognosiAortic RuptureAortic rootRenal functionAorta ThoracicBlood PressureDissection (medical)Thoracic aorta030204 cardiovascular system & hematologyBiologyKidneyRisk Assessment03 medical and health sciences0302 clinical medicineAneurysmAneurysm DissectingChronic kidney diseaseInternal medicinemedicine.arterymedicineAortic rootThoracic aorta030212 general & internal medicineTarget organ damageSettore MED/14 - NefrologiaAortic Aneurysm ThoracicAnimalRisk FactorCardiovascular diseasemedicine.diseaseAneurysmSettore MED/11 - Malattie Dell'Apparato CardiovascolareTarget organ damageSurgeryBlood pressureEchocardiographyHypertensioncardiovascular systemCardiologyGlomerular filtration rateDilatation PathologicHuman
researchProduct

Average real variability of 24-h systolic blood pressure is associated with microalbuminuria in patients with primary hypertension.

2015

Limited and conflicting data are available about the association between short-term blood pressure (BP) variability and urinary albumin excretion rate (uAER). The objective of our study was to analyze the relationships between microalbuminuria (MAU), defined as an uAER between 20 and 200 μg min(-1), and short-term BP variability (BPV), assessed as average real variability (ARV), weighted s.d. of 24-h BP and as s.d. of daytime and night-time BP. The study population consisted of 315 untreated essential hypertensives with normal estimated glomerular filtration rate (>60 ml min(-1) per 1.73 m(2)), who underwent 24-h ambulatory BP monitoring and 24-h uAER determination. MAU was detected in 82 (…

Blood pressure variabilityAdultMalemedicine.medical_specialtyAmbulatory blood pressureSettore MED/09 - Medicina InternamicroalbuminuriaDiastoleRenal functionBlood Pressure030204 cardiovascular system & hematologyEssential hypertension03 medical and health sciences0302 clinical medicineInternal medicinetarget organ damageInternal MedicinemedicineAlbuminuriaHumans030212 general & internal medicineambulatory blood pressureSettore MED/14 - Nefrologiabusiness.industryMiddle Agedmedicine.diseaseSettore MED/11 - Malattie Dell'Apparato CardiovascolareEndocrinologyBlood pressureHypertensionAlbuminuriaCardiologyPopulation studyMicroalbuminuriaFemalemedicine.symptombusinessJournal of human hypertension
researchProduct

Should reduction of increased short‐term blood pressure variability be a target of antihypertensive therapy?

2021

Abstract It has long been known that blood pressure (BP) is characterized by marked short‐term fluctuations occurring within a 24‐h period and also by long‐term oscillations occurring over more prolonged periods of time. An increased short‐term blood pressure variability (BPV) appears to importantly contribute to target organ damage and to the enhanced cardiovascular risk of hypertensive patients, over and above the effect of an increase in mean BP levels. Reducing 24‐h mean BP is the main aim of antihypertensive therapy, but initial data are available that additional cardiovascular protection can be achieved by reducing BPV. However, to definitively prove the prognostic role of short‐term …

Blood pressure variabilityIntervention trialsmedicine.medical_specialtyAmbulatory blood pressureEndocrinology Diabetes and MetabolismBlood Pressure030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineInternal medicineInternal MedicineHypertension generalHumansMedicine030212 general & internal medicineAntihypertensive Agentsbusiness.industryLeft ventricular hypertrophy (LVH) hypertensionBlood Pressure DeterminationAmbulatory blood pressureBlood Pressure Monitoring Ambulatoryhypertension—generalTarget organ damageOrgan damageAntihypertensive AgentBlood pressureHypertensionCommentaryCardiologyCardiology and Cardiovascular MedicinebusinessHumanThe Journal of Clinical Hypertension
researchProduct

Value of home blood pressure as predictor of target organ damage in mild arterial hypertension

2001

Kidneymedicine.medical_specialtyAmbulatory blood pressurebusiness.industryEnd organ damagemedicine.diseaseTarget organ damagemedicine.anatomical_structureBlood pressureInternal medicineInternal MedicineCardiologyMedicineMicroalbuminuriaSystolebusinessAmerican Journal of Hypertension
researchProduct

Metabolic syndrome, organ damage and cardiovascular disease in treated hypertensive patients. The ERIC‐HTA study

2007

The aim of this study is to assess the relationship among metabolic syndrome (MS), target organ damage (TOD) and established cardiovascular disease (CVD) in non-diabetic hypertensive elderly patients. ERIC-HTA is cross-sectional, multicentre study carried out in primary care, on hypertensive patients aged 55 or older. MS was defined by the NCEP-ATP III criteria, using body mass index (28.8 kg/m(2)) instead of abdominal perimeter. In 8331 non-diabetic hypertensive patients (3663 men and 4668 women, mean age 67.7 years), the prevalence of MS was 32.6% (men: 29.0%; women: 36.8%). A linear association was observed between a greater number of components of MS and a greater prevalence of left ven…

Malemedicine.medical_specialtyRenal functionDiseasePrimary careInternal medicinePrevalenceInternal MedicinemedicineHumansAgedMetabolic SyndromeLeft ventricle hypertrophybusiness.industryGeneral MedicineMiddle Agedmedicine.diseaseTarget organ damageOrgan damageCross-Sectional StudiesCardiovascular DiseasesSpainHypertensionCardiologyFemaleHypertrophy Left VentricularMetabolic syndromeCardiology and Cardiovascular MedicinebusinessBody mass indexBlood Pressure
researchProduct

[OP.7D.07] 24-HOUR CENTRAL BLOOD PRESSURE IS BETTER ASSOCIATED WITH TARGET ORGAN DAMAGE OF HYPERTENSION THAN BRACHIAL BLOOD PRESSURE

2017

Objective: The VASOTENS international, multicenter, observational, non-randomized, prospective study aims at evaluating the impact of 24-hour pulse wave analysis of ambulatory blood pressure (BP) recordings on target organ damage and cardiovascular prognosis of hypertensive patients. In the present analysis of study baseline data we checked whether organ damage of hypertension i) is better associated with 24-hour central than peripheral BP and ii) is related to ambulatory arterial stiffness, estimated by pulse wave velocity (PWV) and augmentation index (AIx). Design and method: In 334 hypertensive patients (mean age 53+/-15, 52% males, 45% treated) we obtained 24-hour ABPMs, echocardiograms…

Settore MED/14 - NefrologiaSettore MED/09 - Medicina InternaTarget organ damage.Ambulatory blood pressureAmbulatory blood pressure - Central blood pressure - Target organ damageSettore MED/11 - Malattie Dell'Apparato CardiovascolareCentral blood pressure
researchProduct

The Metabolic Syndrome and Its Relationship to Hypertensive Target Organ Damage

2007

High blood pressure is often associated with various metabolic abnormalities, including abdominal obesity, dyslipidemia, elevated plasma glucose, and insulin resistance, which are the main features of the metabolic syndrome. The metabolic syndrome is extremely common worldwide. This high prevalence is of considerable concern because several studies suggest that the metabolic syndrome carries an increased risk for cardiovascular events. Several lines of evidence seem to indicate that the metabolic syndrome is associated with an increased prevalence of preclinical cardiovascular and renal changes, such as left ventricular hypertrophy, microalbuminuria, impaired aortic elasticity, and early ca…

arterial hypertensionmedicine.medical_specialtySettore MED/09 - Medicina InternaEndocrinology Diabetes and MetabolismLeft ventricular hypertrophyRisk AssessmentInsulin resistanceRisk Factorstarget organ damageInternal medicinePrevalenceInternal MedicinemedicineHumansAbdominal obesityReview Paperbusiness.industrymedicine.diseaseMetabolic syndromeBlood pressureCardiovascular DiseasesHypertensionCardiologyMicroalbuminuriaMetabolic syndromemedicine.symptomCardiology and Cardiovascular MedicineRisk assessmentbusinessDyslipidemiaThe Journal of Clinical Hypertension
researchProduct